alexa Brain pharmacokinetics of tetramethylpyrazine after intranasal and intravenous administration in awake rats.
Pharmaceutical Sciences

Pharmaceutical Sciences

Pharmaceutica Analytica Acta

Author(s): Feng J, Li F, Zhao Y, Feng Y, Abe Y

Abstract Share this page

Abstract Brain pharmacokinetic behaviors of tetramethylpyrazine (TMP) following intranasal (i.n.) and intravenous (i.v.) administration, have been investigated using brain microdialysis technique in free-moving rats. A cross-over design was employed in the present experiment. The same set of rats (n=5) received i.v. injection at a dose of 10 mg/kg TMP via tail vein. Equal dose was administered intranasally. After application, the dialysates sampled from the left striatum were measured by HPLC-UV detection. The results indicated that the mean corrected TMP concentration of 1.49 microg/ml was obtained at 5 min following i.n. dosing while no TMP in the dialysate sampled 5 min after i.v. injection was detected, in the range of our measurement limit. No compartment model was most suitable for analysis of the concentration vs. time results after i.n. dosing. Thus, a non-compartment model was used in the analysis of all experimental data. No significant differences in brain pharmacokinetic parameters, except Cmax, were found between both i.n. and i.v. administration routes. AUCi.n./AUCi.v. ratio was 92.42\%. Finally, compared with i.v. application, intranasal administration of TMP could obtain significantly fast absorption from nasal to ipsilateral striatum and equal bioavailability. Therapeutically relevant nasal formulation is a potential alternative for intravenous administration approach for TMP. This article was published in Int J Pharm and referenced in Pharmaceutica Analytica Acta

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords